1 Min Read
May 2 (Reuters) - Clinuvel Pharmaceuticals Ltd
* Department of health designated scenesse to be evaluated as a highly specialised technology Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.